Patient Treatment & Care Financing

Own the businesses that deliver established patient treatments and finance access to care, rather than research tools or speculative drug-development platforms. The basket combines commercial medicines, medical devices and health coverage, a combination distinct from North's existing drugmaker and life-science portfolios. With technology spending under scrutiny, this offers exposure to recurring clinical needs, while retaining reimbursement, product-safety and drug-pricing risks. Launch basket (equal weight): MDT, JNJ, UNH, ABBV, AMGN, ABT, SYK, BSX Rules: 1. No inverse, leveraged or volatility ETFs. 2. Only names tradable at the enrolled brokers (Moomoo): no OTC listings, no dead tickers, nothing on the refused list.